Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study

1. Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol. 2002; 147:197-213.Search in Google Scholar

2. Colston KW. Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2008; 22:587-99.10.1016/j.beem.2008.08.002Open DOISearch in Google Scholar

3. Ali MM, Vaidya V. Vitamin D and cancer. J Cancer Res Ther. 2007; 3:225-30.10.4103/0973-1482.38998Open DOISearch in Google Scholar

4. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003; 133: 3731-9.10.1093/jn/133.11.3731SSearch in Google Scholar

5. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2002; 132:2413-8.10.1093/jn/132.8.2413SSearch in Google Scholar

6. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem.1999; 10:66-88.10.1016/S0955-2863(98)00074-6Open DOISearch in Google Scholar

7. Graham S, Hellmann R, Marshall J, Freudenheim J, Vena J, Swanson M, et al. Nutritional epidemiology of postmenopausal breast cancer in western New York. Am J Epidemiol. 1991; 134:552-66.10.1093/oxfordjournals.aje.a116129Search in Google Scholar

8. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol. 2007; 106:24-30.10.1016/j.jsbmb.2007.05.012Open DOISearch in Google Scholar

9. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr Relat Cancer. 2005; 12:1071-82.10.1677/erc.1.01038Open DOISearch in Google Scholar

10. Green FL, Page DL, Fleming ID, editors. AJCC Cancer Staging Manuel. 6th ed. Newyork: Springer, 2002. p. 223-40.10.1007/978-1-4757-3656-4Search in Google Scholar

11. Frampton RJ, Omond SA, Eisman JA. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res. 1983; 43:4443-7.Search in Google Scholar

12. Chouvet C, Vicard E, Devonec M, Saez S. 1,25- Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem. 1986; 24:373-6.10.1016/0022-4731(86)90085-3Search in Google Scholar

13. Colston KW, Chander SK, Mackay AG, Coombes RC. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol. 1992; 44:693-702.10.1016/0006-2952(92)90405-8Open DOISearch in Google Scholar

14. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999; 8:399-406.Search in Google Scholar

15. Palmieri C, MacGregor T, Girgis S, Vigushin D. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol. 2006; 59:1334-6.10.1136/jcp.2006.042747Open DOISearch in Google Scholar

16. Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA, Bundred NJ. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab. 1997; 82:118-22.10.1210/jc.82.1.118Search in Google Scholar

17. Liao DJ, Dickson RB. Steroid hormone-growth factor interactions in proliferative controls of the mammary gland and breast cancer: a rapidly evolving perspective. J Steroid Biochem Mol Bio. 2002; 80: 135-6.10.1016/S0960-0760(01)00181-9Open DOISearch in Google Scholar

18. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006; 98:1406-15.10.1093/jnci/djj37617018787Open DOISearch in Google Scholar

19. Baggott JE, Vaughn WH, Juliana MM, Eto I, Krumdieck CL, Grubbs CJ. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst. 1992; 84:1740-4.10.1093/jnci/84.22.17401433358Open DOISearch in Google Scholar